Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,443,247
+$922,448 QoQ
Shares Held
68,749
+31.4% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $203,614,751 across 74 Biotechnology names. HALO ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
100,386 | $44,826,363 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,909 | $33,153,208 | |
| 3 | INSM |
INSMED Inc
|
80,021 | $13,085,033 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,114 | $12,279,909 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
91,463 | $5,734,729 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
68,749 | $4,443,247 | |
| 7 | INCY |
Incyte Corp
|
44,622 | $4,199,821 | |
| 8 | EXEL |
Exelixis, Inc.
|
91,477 | $3,923,448 |
All Filings in HALO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,443,247 | 68,749 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,520,799 | 52,315 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,342,103 | 45,570 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,929,921 | 56,323 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,834,661 | 60,095 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,153,021 | 65,949 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,514,231 | 78,865 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,348,602 | 83,052 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,255,046 | 104,598 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,523,037 | 68,264 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,757,390 | 72,183 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,710,768 | 75,153 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,089,341 | 80,894 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,478,086 | 78,701 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,688,403 | 67,992 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,426,984 | 77,886 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,468,961 | 86,985 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,204,414 | 79,692 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,750,857 | 92,204 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,120,775 | 90,746 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,650,584 | 87,565 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,853,637 | 90,228 | Shares | Defined | 2021-02-16 | |
| 2020-03-31 | $345,425 | 19,201 | Shares | Defined | 2020-06-02 | |
| No filing history on record for this holder in this stock. | ||||||